<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33055142</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>01</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-330X</ISSN><JournalIssue CitedMedium="Internet"><Volume>91</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of neurology, neurosurgery, and psychiatry</Title><ISOAbbreviation>J Neurol Neurosurg Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Cognition and behaviour in frontotemporal dementia with and without amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>1304</StartPage><EndPage>1311</EndPage><MedlinePgn>1304-1311</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1136/jnnp-2020-323969</ELocationID><Abstract><AbstractText Label="OBJECTIVE">The precise relationship between frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) is incompletely understood. The association has been described as a continuum, yet data suggest that this may be an oversimplification. Direct comparisons between patients who have behavioural variant FTD (bvFTD) with and without ALS are rare. This prospective comparative study aimed to determine whether there are phenotypic differences in cognition and behaviour between patients with FTD-ALS and bvFTD alone.</AbstractText><AbstractText Label="METHODS">Patients with bvFTD or FTD-ALS and healthy controls underwent neuropsychological testing, focusing on language, executive functions and social cognition. Behavioural change was measured through caregiver interview. Blood samples were screened for known FTD genes.</AbstractText><AbstractText Label="RESULTS">23 bvFTD, 20 FTD-ALS and 30 controls participated. On cognitive tests, highly significant differences were elicited between patients and controls, confirming the tests' sensitivities to FTD. bvFTD and FTD-ALS groups performed similarly, although with slightly greater difficulty in patients with ALS-FTD on category fluency and a sentence-ordering task that assesses grammar production. Patients with bvFTD demonstrated more widespread behavioural change, with more frequent disinhibition, impulsivity, loss of empathy and repetitive behaviours. Behaviour in FTD-ALS was dominated by apathy. The <i>C9ORF72</i> repeat expansion was associated with poorer performance on language-related tasks.</AbstractText><AbstractText Label="CONCLUSIONS">Differences were elicited in cognition and behaviour between bvFTD and FTD-ALS, and patients carrying the <i>C9ORF72</i> repeat expansion. The findings, which raise the possibility of phenotypic variation between bvFTD and FTD-ALS, have clinical implications for early detection of FTD-ALS and theoretical implications for the nature of the relationship between FTD and ALS.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Saxon</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Jennifer C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Jennifer M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Anna M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langheinrich</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rollinson</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pickering-Brown</LastName><ForeName>Stuart</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chaouch</LastName><ForeName>Amina</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Motor Neurone Disease Care Centre, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ealing</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Motor Neurone Disease Care Centre, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamdalla</LastName><ForeName>Hisham</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Motor Neurone Disease Care Centre, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Young</LastName><ForeName>Carolyn A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blackburn</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Sheffield Institute for Translational Neuroscience (SITraN), The University of Sheffield, Sheffield, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Majeed</LastName><ForeName>Tahir</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Neurology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gall</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Neurology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Snowden</LastName><ForeName>Julie S</ForeName><Initials>JS</Initials><Identifier Source="ORCID">0000-0002-3976-4310</Identifier><AffiliationInfo><Affiliation>Cerebral Function Unit, Manchester Centre for Clinical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK julie.snowden@manchester.ac.uk.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Neuroscience and Experimental Psychology, The University of Manchester, Manchester, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SNOWDEN/OCT13/872-792</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Neurol Neurosurg Psychiatry</MedlineTA><NlmUniqueID>2985191R</NlmUniqueID><ISSNLinking>0022-3050</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Neurol Neurosurg Psychiatry. 2020 Dec;91(12):1255</RefSource><PMID Version="1">33055143</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057565" MajorTopicYN="Y">Apathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004645" MajorTopicYN="N">Empathy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056344" MajorTopicYN="N">Executive Function</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="Y">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007175" MajorTopicYN="Y">Impulsive Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007266" MajorTopicYN="Y">Inhibition, Psychological</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007802" MajorTopicYN="N">Language</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009483" MajorTopicYN="N">Neuropsychological Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000083282" MajorTopicYN="Y">Social Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013239" MajorTopicYN="N">Stereotyped Behavior</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>15</Day><Hour>17</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33055142</ArticleId><ArticleId IdType="pmc">PMC7677467</ArticleId><ArticleId IdType="doi">10.1136/jnnp-2020-323969</ArticleId><ArticleId IdType="pii">jnnp-2020-323969</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Robberecht W, Philips T. The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 2013;14:248&#x2013;64. 10.1038/nrn3430</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn3430</ArticleId><ArticleId IdType="pubmed">23463272</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxon JA, Harris JM, Thompson JC, et al. . Semantic dementia, progressive non-fluent aphasia and their association with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2017;88:711&#x2013;2. 10.1136/jnnp-2016-314912</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314912</ArticleId><ArticleId IdType="pmc">PMC5537533</ArticleId><ArticleId IdType="pubmed">28554960</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, Halliday GM, Kril JJ, et al. . The frontotemporal dementia-motor neuron disease continuum. Lancet 2016;388:919&#x2013;31. 10.1016/S0140-6736(16)00737-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E, Raaphorst J, Klein Twennaar M, et al. . The cognitive profile of behavioural variant FTD and its similarities with ALS: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2018;89:995&#x2013;1002. 10.1136/jnnp-2017-317459</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317459</ArticleId><ArticleId IdType="pubmed">29439163</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, et al. . Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130&#x2013;3. 10.1126/science.1134108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. . Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011;72:245&#x2013;56. 10.1016/j.neuron.2011.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, et al. . A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011;72:257&#x2013;68. 10.1016/j.neuron.2011.09.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeve BF, Boylan KB, Graff-Radford NR, et al. . Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 2012;135:765&#x2013;83. 10.1093/brain/aws004</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws004</ArticleId><ArticleId IdType="pmc">PMC3286335</ArticleId><ArticleId IdType="pubmed">22366793</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden JS, Rollinson S, Thompson JC, et al. . Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012;135:693&#x2013;708. 10.1093/brain/awr355</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr355</ArticleId><ArticleId IdType="pmc">PMC3286329</ArticleId><ArticleId IdType="pubmed">22300873</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Savage S, Mioshi E, et al. . Amyotrophic lateral sclerosis and frontotemporal dementia: a behavioural and cognitive continuum. Amyotroph Lateral Scler 2012;13:102&#x2013;9. 10.3109/17482968.2011.639376</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482968.2011.639376</ArticleId><ArticleId IdType="pubmed">22214356</ArticleId></ArticleIdList></Reference><Reference><Citation>Lul&#xe9; DE, Aho-&#xd6;zhan HEA, V&#xe1;zquez C, et al. . Story of the ALS-FTD continuum retold: rather two distinct entities. J Neurol Neurosurg Psychiatry 2019;90:586&#x2013;9. 10.1136/jnnp-2018-318800</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318800</ArticleId><ArticleId IdType="pubmed">30257969</ArticleId></ArticleIdList></Reference><Reference><Citation>Mann DMA, Snowden JS. Frontotemporal lobar degeneration: pathogenesis, pathology and pathways to phenotype. Brain Pathol 2017;27:723&#x2013;36. 10.1111/bpa.12486</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12486</ArticleId><ArticleId IdType="pmc">PMC8029341</ArticleId><ArticleId IdType="pubmed">28100023</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Z, Irish M, Piguet O, et al. . Clinical and neuroimaging investigations of language disturbance in frontotemporal dementia-motor neuron disease patients. J Neurol 2019;266:921&#x2013;33. 10.1007/s00415-019-09216-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09216-0</ArticleId><ArticleId IdType="pubmed">30707358</ArticleId></ArticleIdList></Reference><Reference><Citation>De Silva D, Hsieh S, Caga J, et al. . Motor function and behaviour across the ALS-FTD spectrum. Acta Neurol Scand 2016;133:367&#x2013;72. 10.1111/ane.12471</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12471</ArticleId><ArticleId IdType="pubmed">26223148</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Garcin B, Hornberger M, et al. . Neurobehavioral features in frontotemporal dementia with amyotrophic lateral sclerosis. Arch Neurol 2010;67:826&#x2013;30. 10.1001/archneurol.2010.146</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2010.146</ArticleId><ArticleId IdType="pubmed">20625088</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxon JA, Thompson JC, Jones M, et al. . Examining the language and behavioural profile in FTD and ALS-FTD. J Neurol Neurosurg Psychiatry 2017;88:675&#x2013;80. 10.1136/jnnp-2017-315667</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315667</ArticleId><ArticleId IdType="pmc">PMC5537548</ArticleId><ArticleId IdType="pubmed">28596248</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman DS, Kramer JH, Boeve BF, et al. . Development of methodology for conducting clinical trials in frontotemporal lobar degeneration. Brain 2008;131:2957&#x2013;68. 10.1093/brain/awn234</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn234</ArticleId><ArticleId IdType="pmc">PMC2725027</ArticleId><ArticleId IdType="pubmed">18829698</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, et al. . Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011;134:2456&#x2013;77. 10.1093/brain/awr179</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, et al. . El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293&#x2013;9. 10.1080/146608200300079536</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et al. . The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (phase 111). J Neurol Sci 1999;169:13&#x2013;21. 10.1016/S0022-510X(99)00210-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(99)00210-5</ArticleId><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>McKenna P, Warrington EK. Graded naming test. Cambridge cognition, 1980.</Citation></Reference><Reference><Citation>Druks J, Masterson J. The object and action naming battery, 2000.</Citation></Reference><Reference><Citation>Howard D. Patterson K pyramids and palm trees test. London: Pearson Assessment, 1992.</Citation></Reference><Reference><Citation>Kay J, Coltheart M, Lesser R. PALPA: Psycholinguistic assessment of language processing in aphasia. London: Routledge, 1992.</Citation></Reference><Reference><Citation>Harris JM, Saxon JA, Jones M, et al. . Neuropsychological differentiation of progressive aphasic disorders. J Neuropsychol 2019;13:214&#x2013;39. 10.1111/jnp.12149</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnp.12149</ArticleId><ArticleId IdType="pmc">PMC6618014</ArticleId><ArticleId IdType="pubmed">29424041</ArticleId></ArticleIdList></Reference><Reference><Citation>Delis DC, Kaplan E, Kramer JH. Delis-Kaplan executive function system (D-KEFS). London: Pearson Assessment, 2001.</Citation></Reference><Reference><Citation>Burgess PW, Shallice T. Hayling and Brixton tests. London: Pearson Assessment,, 1997.</Citation></Reference><Reference><Citation>Baron-Cohen S, Campbell R, Karmiloff-Smith A, et al. . Are children with autism blind to the mentalistic significance of the eyes? Br J Dev Psychol 1995;13:379&#x2013;98. 10.1111/j.2044-835X.1995.tb00687.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-835X.1995.tb00687.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Ekman P, Friesen W. Pictures of facial affect. Palo Alto, CA: Consulting Psychologists Press, 1976.</Citation></Reference><Reference><Citation>Abrahams S, Leigh PN, Harvey A, et al. . Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). Neuropsychologia 2000;38:734&#x2013;47. 10.1016/S0028-3932(99)00146-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0028-3932(99)00146-3</ArticleId><ArticleId IdType="pubmed">10689049</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, et al. . The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308&#x2013;14. 10.1212/WNL.44.12.2308</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.44.12.2308</ArticleId><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Grace J, Malloy P. Frontal systems behaviour scale (FrSBe). Lutz, PL: Psychological Assessment Resources Inc, 2001.</Citation></Reference><Reference><Citation>Kamminga J, Leslie FVC, Hsieh S, et al. . Syntactic comprehension deficits across the FTD-ALS continuum. Neurobiol Aging 2016;41:11&#x2013;18. 10.1016/j.neurobiolaging.2016.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.02.002</ArticleId><ArticleId IdType="pubmed">27103514</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsermentseli S, Leigh PN, Taylor LJ, et al. . Syntactic processing as a marker for cognitive impairment in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2015;17:69&#x2013;76. 10.3109/21678421.2015.1071397</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1071397</ArticleId><ArticleId IdType="pmc">PMC4732449</ArticleId><ArticleId IdType="pubmed">26312952</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie FVC, Hsieh S, Caga J, et al. . Semantic deficits in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 2015;16:46&#x2013;53. 10.3109/21678421.2014.987301</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.987301</ArticleId><ArticleId IdType="pubmed">25544644</ArticleId></ArticleIdList></Reference><Reference><Citation>Devenney EM, Landin-Romero R, Irish M, et al. . The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion. Neuroimage Clin 2017;13:439&#x2013;45. 10.1016/j.nicl.2016.11.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2016.11.028</ArticleId><ArticleId IdType="pmc">PMC5233794</ArticleId><ArticleId IdType="pubmed">28116236</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Langenhove T, Piguet O, Burrell JR, et al. . Predicting development of amyotrophic lateral sclerosis in frontotemporal dementia. J Alzheimers Dis 2017;58:163&#x2013;70. 10.3233/JAD-161272</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-161272</ArticleId><ArticleId IdType="pubmed">28387671</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>